Evidence map›Paper›PMID 38371792›Full record

ArticleACS omega2024

Surface-Enhanced Raman Scattering (SERS) in Combination with PCA and PLS-DA for the Evaluation of Antibacterial Activity of 1-Isopentyl-3-pentyl-1

Fatima Tahir, Ali Kamran, Muhammad Irfan Majeed, Abeer Ahmed Alghamdi, Muhammad Rizwan Javed, Haq Nawaz, Muhammad Adnan Iqbal, Muhammad Tahir, Anam Tariq, Nosheen Rashid and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
11.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 17 citations in OpenAlex.

  1. Characterization of theInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Synthetic Plantaricins Derived fromJournal of microbiology and biotechnology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Fatima TahirDepartment of Chemistry, University of Agriculture Faisalabad, Faisalabad 38000, Pakistan.
Ali KamranDepartment of Chemistry, University of Agriculture Faisalabad, Faisalabad 38000, Pakistan.
Muhammad Irfan MajeedDepartment of Chemistry, University of Agriculture Faisalabad, Faisalabad 38000, Pakistan.ORCID https://orcid.org/0000-0003-0506-6060
Abeer Ahmed AlghamdiDepartment of Physics, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
Muhammad Rizwan JavedDepartment of Bioinformatics and Biotechnology, Government College University Faisalabad (GCUF), Faisalabad 38000, Pakistan.
Haq NawazDepartment of Chemistry, University of Agriculture Faisalabad, Faisalabad 38000, Pakistan.ORCID https://orcid.org/0000-0003-2739-4735
Muhammad Adnan IqbalDepartment of Chemistry, University of Agriculture Faisalabad, Faisalabad 38000, Pakistan.ORCID https://orcid.org/0000-0001-6241-7547
Muhammad TahirDepartment of Chemistry, University of Agriculture Faisalabad, Faisalabad 38000, Pakistan.
Anam TariqDepartment of Biochemistry, Government College University Faisalabad (GCUF), Faisalabad 38000, Pakistan.
Nosheen RashidDepartment of Chemistry, University of Education, Faisalabad Campus, Faisalabad 38000, Pakistan.
Urwa ShahidDepartment of Chemistry, University of Agriculture Faisalabad, Faisalabad 38000, Pakistan.
Ahmad HassanDepartment of Chemistry, University of Agriculture Faisalabad, Faisalabad 38000, Pakistan.
Umar Sohail ShoukatDepartment of Chemistry, University of Agriculture Faisalabad, Faisalabad 38000, Pakistan.
University of Faisalabad · PKGovernment College University, Faisalabad · PKPrincess Nourah bint Abdulrahman University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the current study, surface-enhanced Raman scattering (SERS) was performed to evaluate the antibacterial activity of lab-synthesized drug (1-isopentyl-3-pentyl-1

Identifiers

PMID38371792
PMCPMC10870359
OpenAlexW4391346118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.